应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMUX Immunic, Inc.
盘后交易 06-18 17:41:40 EDT
0.7464
-0.0211
-2.75%
盘后
0.7770
+0.0306
+4.10%
17:30 EDT
最高
0.8150
最低
0.7078
成交量
118.86万
今开
0.8028
昨收
0.7675
日振幅
13.97%
总市值
7,152万
流通市值
5,694万
总股本
9,582万
成交额
89.11万
换手率
1.56%
流通股本
7,628万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Immunic, Inc.盘中异动 早盘快速下跌5.30%
市场透视 · 06-17 23:21
Immunic, Inc.盘中异动 早盘快速下跌5.30%
Immunic, Inc.盘中异动 大幅下挫5.14%报0.801美元
市场透视 · 06-14
Immunic, Inc.盘中异动 大幅下挫5.14%报0.801美元
Immunic, Inc.盘中异动 急速下跌5.17%
市场透视 · 06-12
Immunic, Inc.盘中异动 急速下跌5.17%
Immunic, Inc.盘中异动 股价大涨5.14%
市场透视 · 06-10
Immunic, Inc.盘中异动 股价大涨5.14%
Immunic, Inc.盘中异动 早盘股价大涨5.10%报0.812美元
市场透视 · 06-06
Immunic, Inc.盘中异动 早盘股价大涨5.10%报0.812美元
Immunic, Inc.盘中异动 早盘股价大涨5.39%
市场透视 · 06-04
Immunic, Inc.盘中异动 早盘股价大涨5.39%
Immunic, Inc.盘中异动 快速上涨5.93%报0.699美元
市场透视 · 06-02
Immunic, Inc.盘中异动 快速上涨5.93%报0.699美元
Immunic, Inc.盘中异动 早盘大幅拉升5.00%报0.714美元
市场透视 · 05-30
Immunic, Inc.盘中异动 早盘大幅拉升5.00%报0.714美元
B. Riley Securities:重申Immunic评级,由买入调整至买入评级, 目标价由6.00美元调整至5.00美元。
金融界 · 05-23
B. Riley Securities:重申Immunic评级,由买入调整至买入评级, 目标价由6.00美元调整至5.00美元。
Immunic, Inc.盘中异动 大幅拉升6.57%
市场透视 · 05-08
Immunic, Inc.盘中异动 大幅拉升6.57%
Immunic, Inc.盘中异动 股价大跌6.44%
市场透视 · 05-08
Immunic, Inc.盘中异动 股价大跌6.44%
Immunic, Inc.盘中异动 早盘股价大跌8.59%报1.17美元
市场透视 · 04-30
Immunic, Inc.盘中异动 早盘股价大跌8.59%报1.17美元
Immunic, Inc.盘中异动 大幅上涨5.36%报1.18美元
市场透视 · 04-30
Immunic, Inc.盘中异动 大幅上涨5.36%报1.18美元
Immunic, Inc.盘中异动 早盘股价大涨5.00%报1.05美元
市场透视 · 04-23
Immunic, Inc.盘中异动 早盘股价大涨5.00%报1.05美元
Immunic, Inc.盘中异动 早盘股价大涨5.15%
市场透视 · 04-22
Immunic, Inc.盘中异动 早盘股价大涨5.15%
Immunic, Inc.盘中异动 大幅上涨5.10%
市场透视 · 04-21
Immunic, Inc.盘中异动 大幅上涨5.10%
Immunic, Inc.盘中异动 早盘股价大跌5.45%
市场透视 · 04-16
Immunic, Inc.盘中异动 早盘股价大跌5.45%
Immunic, Inc.盘中异动 早盘股价大涨7.30%
市场透视 · 04-14
Immunic, Inc.盘中异动 早盘股价大涨7.30%
Immunic, Inc.盘中异动 下午盘大幅下挫5.22%报1.09美元
市场透视 · 03-11
Immunic, Inc.盘中异动 下午盘大幅下挫5.22%报1.09美元
Immunic, Inc.盘中异动 股价大跌5.17%报1.10美元
市场透视 · 03-04
Immunic, Inc.盘中异动 股价大跌5.17%报1.10美元
加载更多
公司概况
公司名称:
Immunic, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Immunic, Inc.通过收购VitaGen公司的资产和业务,作为一个加利福尼亚州的公司于2003年5月23日开始运营,并于2003年6月更名为Vital生命治疗有限公司。2004年1月,公司再次在特拉华州注册成立。公司是一家生物治疗公司,致力于开发基于细胞的急性肝功能衰竭的治疗。候选产品目前在三期临床试验中,ELAD系统(或ELAD)是一个体外生物人工肝治疗,目的是在病人移植之前让病人自己的肝脏再生一个健康的状态或稳定的肝脏。自成立以来,它已经基本上倾注了全部的努力至产品开发、临床试验和试生产,还没有意识到收入来自计划主营业务。
发行价格:
--
{"stockData":{"symbol":"IMUX","market":"US","secType":"STK","nameCN":"Immunic, Inc.","latestPrice":0.7464,"timestamp":1750276800000,"preClose":0.7675,"halted":0,"volume":1188614,"hourTrading":{"tag":"盘后","latestPrice":0.777,"preClose":0.7464,"latestTime":"17:30 EDT","volume":5462,"amount":4170.474597,"timestamp":1750282207650},"delay":0,"floatShares":76283176,"shares":95817536,"eps":-0.952662,"marketStatus":"盘后交易","change":-0.0211,"latestTime":"06-18 17:41:40 EDT","open":0.8028,"high":0.815,"low":0.7078,"amount":891105.4609982,"amplitude":0.139674,"askPrice":0.79,"askSize":3000,"bidPrice":0.7101,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-0.952662,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1750291200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1397707200000,"exchange":"NASDAQ","adjPreClose":0.7675,"preHourTrading":{"tag":"盘前","latestPrice":0.795,"preClose":0.7675,"latestTime":"09:26 EDT","volume":22140,"amount":17924.5557342,"timestamp":1750253214428},"postHourTrading":{"tag":"盘后","latestPrice":0.777,"preClose":0.7464,"latestTime":"17:30 EDT","volume":5462,"amount":4170.474597,"timestamp":1750282207650},"volumeRatio":1.170163,"impliedVol":1.2382,"impliedVolPercentile":0.916},"requestUrl":"/m/hq/s/IMUX","defaultTab":"news","newsList":[{"id":"2544996459","title":"Immunic, Inc.盘中异动 早盘快速下跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544996459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544996459?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:21","pubTimestamp":1750173707,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日23时21分,Immunic, Inc.股票出现波动,股价大幅下挫5.30%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061723214897839335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061723214897839335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2543302726","title":"Immunic, Inc.盘中异动 大幅下挫5.14%报0.801美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543302726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543302726?lang=zh_cn&edition=full","pubTime":"2025-06-14 04:00","pubTimestamp":1749844811,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日04时00分,Immunic, Inc.股票出现波动,股价急速跳水5.14%。截至发稿,该股报0.801美元/股,成交量94.7248万股,换手率0.99%,振幅6.54%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614040011951b8378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614040011951b8378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2542358510","title":"Immunic, Inc.盘中异动 急速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542358510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542358510?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:39","pubTimestamp":1749735562,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时39分,Immunic, Inc.股票出现异动,股价大幅下挫5.17%。截至发稿,该股报0.825美元/股,成交量16.0928万股,换手率0.17%,振幅6.10%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.47%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213922977cb04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213922977cb04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2542458013","title":"Immunic, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542458013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542458013?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:58","pubTimestamp":1749567531,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时58分,Immunic, Inc.股票出现异动,股价快速拉升5.14%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610225851a4a21d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610225851a4a21d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2541869343","title":"Immunic, Inc.盘中异动 早盘股价大涨5.10%报0.812美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541869343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541869343?lang=zh_cn&edition=full","pubTime":"2025-06-06 23:01","pubTimestamp":1749222085,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日23时01分,Immunic, Inc.股票出现异动,股价大幅上涨5.10%。截至发稿,该股报0.812美元/股,成交量111.177万股,换手率1.16%,振幅6.77%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060623012697748338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060623012697748338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2540064105","title":"Immunic, Inc.盘中异动 早盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540064105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540064105?lang=zh_cn&edition=full","pubTime":"2025-06-04 21:50","pubTimestamp":1749045003,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日21时50分,Immunic, Inc.股票出现波动,股价急速拉升5.39%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604215003977191cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604215003977191cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2540579577","title":"Immunic, Inc.盘中异动 快速上涨5.93%报0.699美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540579577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540579577?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:38","pubTimestamp":1748871487,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时38分,Immunic, Inc.股票出现波动,股价快速拉升5.93%。截至发稿,该股报0.699美元/股,成交量25.3208万股,换手率0.26%,振幅1.65%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.99%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213808976e8206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213808976e8206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2539278073","title":"Immunic, Inc.盘中异动 早盘大幅拉升5.00%报0.714美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539278073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539278073?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:31","pubTimestamp":1748611901,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时31分,Immunic, Inc.股票出现波动,股价快速拉升5.00%。截至发稿,该股报0.714美元/股,成交量50.4401万股,换手率0.53%,振幅2.94%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为2.82%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213142a6f36e7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213142a6f36e7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2537713292","title":"B. Riley Securities:重申Immunic评级,由买入调整至买入评级, 目标价由6.00美元调整至5.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537713292","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537713292?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:31","pubTimestamp":1748007061,"startTime":"0","endTime":"0","summary":"B. Riley Securities:重申Immunic(IMUX.US)评级,由买入调整至买入评级, 目标价由6.00美元调整至5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052321354595007ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052321354595007ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX"],"gpt_icon":0},{"id":"2533532136","title":"Immunic, Inc.盘中异动 大幅拉升6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533532136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533532136?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:30","pubTimestamp":1746711035,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时30分,Immunic, Inc.股票出现异动,股价急速上涨6.57%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213036a6d7c34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508213036a6d7c34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2533954042","title":"Immunic, Inc.盘中异动 股价大跌6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533954042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533954042?lang=zh_cn&edition=full","pubTime":"2025-05-08 01:46","pubTimestamp":1746639983,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日01时46分,Immunic, Inc.股票出现波动,股价急速跳水6.44%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为0.81%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050801462394ef7da5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050801462394ef7da5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2531405316","title":"Immunic, Inc.盘中异动 早盘股价大跌8.59%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531405316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531405316?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:31","pubTimestamp":1746019867,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时31分,Immunic, Inc.股票出现波动,股价大幅下挫8.59%。截至发稿,该股报1.17美元/股,成交量170.203万股,换手率1.78%,振幅3.13%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213107a6cee78d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213107a6cee78d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2531766280","title":"Immunic, Inc.盘中异动 大幅上涨5.36%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531766280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531766280?lang=zh_cn&edition=full","pubTime":"2025-04-30 00:38","pubTimestamp":1745944702,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日00时38分,Immunic, Inc.股票出现波动,股价大幅拉升5.36%。截至发稿,该股报1.18美元/股,成交量43.1557万股,换手率0.45%,振幅5.80%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430003822a46c6d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430003822a46c6d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2529268272","title":"Immunic, Inc.盘中异动 早盘股价大涨5.00%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529268272?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:39","pubTimestamp":1745415580,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时39分,Immunic, Inc.股票出现异动,股价急速拉升5.00%。截至发稿,该股报1.05美元/股,成交量14.6299万股,换手率0.15%,振幅3.50%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.78%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321394097423498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321394097423498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2529586123","title":"Immunic, Inc.盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529586123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529586123?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:37","pubTimestamp":1745329054,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时37分,Immunic, Inc.股票出现波动,股价快速上涨5.15%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.98%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213734aa2c75fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213734aa2c75fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2529766807","title":"Immunic, Inc.盘中异动 大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529766807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529766807?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:05","pubTimestamp":1745244329,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时05分,Immunic, Inc.股票出现异动,股价急速上涨5.10%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220529a461272f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421220529a461272f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2527524439","title":"Immunic, Inc.盘中异动 早盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527524439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527524439?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:16","pubTimestamp":1744813013,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时16分,Immunic, Inc.股票出现异动,股价快速下挫5.45%。Immunic, Inc.股票所在的生物技术行业中,整体跌幅为1.56%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416221654973a0a03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416221654973a0a03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0},{"id":"2527405164","title":"Immunic, Inc.盘中异动 早盘股价大涨7.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527405164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527405164?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:31","pubTimestamp":1744637479,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分,Immunic, Inc.股票出现波动,股价大幅拉升7.30%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213120aa2c6dff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213120aa2c6dff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2518970204","title":"Immunic, Inc.盘中异动 下午盘大幅下挫5.22%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518970204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518970204?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:23","pubTimestamp":1741630982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时23分,Immunic, Inc.股票出现波动,股价急速下挫5.22%。截至发稿,该股报1.09美元/股,成交量55.6483万股,换手率0.62%,振幅4.34%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311022302abf366de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311022302abf366de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMUX","BK4139"],"gpt_icon":0},{"id":"2516773256","title":"Immunic, Inc.盘中异动 股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516773256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516773256?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098950,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分,Immunic, Inc.股票出现异动,股价急速下挫5.17%。截至发稿,该股报1.10美元/股,成交量6.0825万股,换手率0.07%,振幅3.02%。Immunic, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Immunic, Inc.公司简介:Immunic Inc 是一家临床阶段生物制药公司,正在开发一系列选择性口服免疫疗法,旨在治疗慢性炎症和自身免疫性疾病,包括溃疡性结肠炎,克罗恩病,复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223550963945e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223550963945e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMUX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.imux.com","stockEarnings":[{"period":"1week","weight":-0.1331},{"period":"1month","weight":-0.2014},{"period":"3month","weight":-0.3384},{"period":"6month","weight":-0.262},{"period":"1year","weight":-0.3268},{"period":"ytd","weight":-0.2325}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":0.0056},{"period":"3month","weight":0.0536},{"period":"6month","weight":0.0195},{"period":"1year","weight":0.0922},{"period":"ytd","weight":0.0195}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunic, Inc.通过收购VitaGen公司的资产和业务,作为一个加利福尼亚州的公司于2003年5月23日开始运营,并于2003年6月更名为Vital生命治疗有限公司。2004年1月,公司再次在特拉华州注册成立。公司是一家生物治疗公司,致力于开发基于细胞的急性肝功能衰竭的治疗。候选产品目前在三期临床试验中,ELAD系统(或ELAD)是一个体外生物人工肝治疗,目的是在病人移植之前让病人自己的肝脏再生一个健康的状态或稳定的肝脏。自成立以来,它已经基本上倾注了全部的努力至产品开发、临床试验和试生产,还没有意识到收入来自计划主营业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.051217},{"month":2,"riseRate":0.363636,"avgChangeRate":0.009296},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.045158},{"month":4,"riseRate":0.272727,"avgChangeRate":0.040308},{"month":5,"riseRate":0.090909,"avgChangeRate":-0.095662},{"month":6,"riseRate":0.583333,"avgChangeRate":0.143339},{"month":7,"riseRate":0.545455,"avgChangeRate":0.02756},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.034318},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.086965},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.027926},{"month":11,"riseRate":0.545455,"avgChangeRate":0.005972},{"month":12,"riseRate":0.636364,"avgChangeRate":0.045715}],"exchange":"NASDAQ","name":"Immunic, Inc.","nameEN":"Immunic, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.0","shortVersion":"4.34.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunic, Inc.(IMUX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunic, Inc.,IMUX,Immunic, Inc.股票,Immunic, Inc.股票老虎,Immunic, Inc.股票老虎国际,Immunic, Inc.行情,Immunic, Inc.股票行情,Immunic, Inc.股价,Immunic, Inc.股市,Immunic, Inc.股票价格,Immunic, Inc.股票交易,Immunic, Inc.股票购买,Immunic, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunic, Inc.(IMUX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}